Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hans-Joerg Buehring is active.

Publication


Featured researches published by Hans-Joerg Buehring.


Nature | 2010

Human adult germline stem cells in question Reply

Sabine Conrad; Markus Renninger; Joerg Hennenlotter; Tina Wiesner; Lothar Just; Michael Bonin; Wilhelm K. Aicher; Hans-Joerg Buehring; Ulrich Mattheus; Andreas F. Mack; Hans-Joachim Wagner; Stephen Minger; Matthias Matzkies; Michael Reppel; Juergen Hescheler; Karl-Dietrich Sievert; Arnulf Stenzl; Thomas Skutella

Replying to: K. Ko et al. 465, 10.1038/nature09089 (2010)Ko et al. challenge our description of human adult germline stem cells (haGSCs), indicating that we have instead cultured testis fibroblasts. However, they do not follow the experimental procedures we describe and so fail to reproduce our findings.


Archive | 2007

Monoclonal antibody against frizzled receptors

Hans-Joerg Buehring; Sigrid Hojak; Ingrid Albert


Archive | 2009

ISOLATION AND/OR IDENTIFICATION OF STEM CELLS HAVING ADIPOCYTIC, CHONDROCYTIC AND PANCREATIC DIFFERENTIATION POTENTIAL

Hans-Joerg Buehring; Sabrina Treml; Reiner Lammers


Archive | 2005

Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/or identifying neuronal progenitor cells

Hans-Joerg Buehring; Wichard Vogel


Blood | 2014

Development and Preclinical Characterization of an Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity Against Myeloid Leukemia

Samuel Koerner; Julia Leibold; Ludger Grosse-Hovest; Hans-Joerg Buehring; Gundram Jung; Lothar Kanz; Helmut R. Salih


Blood | 2015

Epigenetic Upregulation of the O-Linked Beta-N-Acetylglucosamine Transferase (OGT) in Response to Dronabinol Results in Antileukemic Efficacy In Vivo

Kerstin M Kampa-Schittenhelm; Hans-Joerg Buehring; Michael Bonin; Wichard Vogel; Lothar Kanz; Thomas Haverkamp; Marcus M Schittenhelm


Archive | 2013

Novel msc surface marker

Hans-Joerg Buehring; Sabrina Grimm; Flavianna Cerabona


Blood | 2013

Elimination Of Minimal Residual Disease (MRD) In AML Patients With a Novel Fc-Optimized FLT3 Antibody (4G8-SDIEM)

Martin Hofmann; Ludger Grosse-Hovest; Tina Nuebling; Maximilian Bamberg; Steffen Aulwurm; Hans-Joerg Buehring; Wolfgang Bethge; Lothar Kanz; Gundram Jung


Archive | 2010

Anti-FLT3 antibodies

Ludger Grosse-Hovest; Hans-Joerg Buehring; Martin Hofmann; Steffen Aulwurm; Grundram Jung


Journal of Clinical Oncology | 2017

Aldehyde dehydrogenase activity in serous ovarian carcinoma.

Petra M. Bareiss; Tanja Fehm; Anna Fischer; Matthias Grauer; Philipp Kokorsch; Hans-Joerg Buehring; Deborah Pham; Annette Staebler; Diethelm Wallwiener; Falko Fend; Lothar Kanz; Claudia Lengerke

Collaboration


Dive into the Hans-Joerg Buehring's collaboration.

Top Co-Authors

Avatar

Lothar Kanz

University of Tübingen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gundram Jung

University of Tübingen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sigrid Hojak

University of Tübingen

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge